MindMed (MNMD) stock is expanding the psychedelic’s market for investors
MindMed is a clinical stage psychedelic medicine biotech company. This biotech company specifically focuses on the discovery and development of innovative therapies and medicines that target psychological and mental illness like an addiction. The pipeline of the company includes the development of psychedelic substances which include 18-MC, Dimethyltryptamine (DMT), MDMA, Lysergic acid Diethylamide, Psilobycin and […]
